Edition:
United States

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

2.29USD
22 Jun 2018
Change (% chg)

$-0.10 (-4.18%)
Prev Close
$2.39
Open
$2.40
Day's High
$2.40
Day's Low
$2.27
Volume
34,208
Avg. Vol
13,123
52-wk High
$79.05
52-wk Low
$2.12

Latest Key Developments (Source: Significant Developments)

ReShape Lifesciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market
Wednesday, 20 Jun 2018 09:00am EDT 

June 20 (Reuters) - ReShape Lifesciences Inc ::RESHAPE LIFESCIENCES ANNOUNCES $1.5 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET.RESHAPE LIFESCIENCES - ENTERED INTO DEFINITIVE AGREEMENTS WITH SEVERAL INSTITUTIONAL INVESTORS FOR PURCHASE OF 469,490 SHARES AT $3.07/SHARE.RESHAPE LIFESCIENCES - INTENDS TO USE $0.5 MILLION OF NET PROCEEDS FROM OFFERING TO PARTIALLY REDEEM OUTSTANDING SHARES OF SERIES D PREFERRED STOCK.  Full Article

Reshape Lifesciences Says One Reported Death Of Patient With Reshape Balloon Since Aug 10 FDA Letter
Monday, 4 Jun 2018 01:57pm EDT 

June 4 (Reuters) - ReShape Lifesciences Inc ::RESHAPE LIFESCIENCES PROVIDES UPDATE ON FDA LETTER TO HEALTH CARE PROVIDERS RELATED TO INTRAGASTRIC BALLOONS.RESHAPE LIFESCIENCES - PROVIDED AN EXPLANATION & CLARIFYING DETAILS TO LETTER DATED JUNE 4, 2018 THAT U.S. FDA POSTED ON THEIR WEBSITE.RESHAPE LIFESCIENCES SAYS THERE HAS BEEN ONE REPORTED DEATH OF A PATIENT IMPLANTED WITH A RESHAPE BALLOON SINCE AUGUST 10, 2017 LETTER FROM FDA.RESHAPE LIFESCIENCES -THE 1 REPORTED PATIENT DEATH WAS DUE TO PULMONARY EMBOLIZATION SECONDARY TO SURGICAL REPAIR OF A GASTRIC PERFORATION.  Full Article

Reshape Lifesciences Files For Mixed Shelf Of Up To $125 Mln
Monday, 21 May 2018 05:04pm EDT 

May 21 (Reuters) - ReShape Lifesciences Inc ::RESHAPE LIFESCIENCES FILES FOR MIXED SHELF OF UP TO $125 MILLION - SEC FILING.  Full Article

ReShape Lifesciences Qtrly Loss Per Share $0.36
Monday, 14 May 2018 04:04pm EDT 

May 14 (Reuters) - ReShape Lifesciences Inc ::RESHAPE LIFESCIENCES ANNOUNCES RECORD REVENUE FOR FIRST QUARTER 2018.Q1 REVENUE $950,000.QTRLY LOSS PER SHARE $0.36.  Full Article

Reshape Lifesciences Reports Qtrly Loss Per Share Of $0.45‍​
Monday, 2 Apr 2018 04:01pm EDT 

April 2 (Reuters) - ReShape Lifesciences Inc ::RESHAPE LIFESCIENCES ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS.Q4 SALES $794,000.QTRLY LOSS PER SHARE $0.45‍​.  Full Article

ReShape Lifesciences Agrees With Academy Medical To Provide Reshape Balloon To Department Of Defense Facilities
Wednesday, 7 Mar 2018 08:00am EST 

March 7 (Reuters) - Reshape Lifesciences Inc ::RESHAPE LIFESCIENCES ANNOUNCES AGREEMENT WITH ACADEMY MEDICAL TO PROVIDE RESHAPE BALLOON AND RESHAPE VBLOC TO DEPARTMENT OF DEFENSE FACILITIES.RESHAPE LIFESCIENCES - ‍ THROUGH DEAL, RESHAPE BALLOON & RESHAPE VBLOC ARE APPROVED PRODUCTS FOR SALE INTO DOD MEDICAL FACILITIES​.  Full Article

ReShape Lifesciences Q4 Preliminary Revenue About $795,000
Thursday, 1 Feb 2018 07:00am EST 

Feb 1 (Reuters) - Reshape Lifesciences Inc ::RESHAPE LIFESCIENCES REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 REVENUE.RESHAPE LIFESCIENCES INC - PRELIMINARY REVENUE FOR Q4 2017 IS EXPECTED TO BE APPROXIMATELY $795,000.RESHAPE LIFESCIENCES INC - PRELIMINARY AND UNAUDITED REVENUE FOR FULL YEAR 2017 IS EXPECTED TO BE APPROXIMATELY $1.3 MILLION.  Full Article

SVLSF IV Reports 14 Pct Passive Stake In Reshape Lifesciences
Friday, 29 Dec 2017 10:30am EST 

Dec 29 (Reuters) - Reshape Lifesciences Inc ::SVLSF IV, LLC REPORTS 14 PERCENT PASSIVE STAKE IN RESHAPE LIFESCIENCES AS OF DEC 19 - SEC FILING.  Full Article

Reshape Lifesciences Inc - ‍Received Order For Reshape Integrated Dual Balloon System From Al Zahrawi ​
Wednesday, 13 Dec 2017 08:15am EST 

Dec 13 (Reuters) - Reshape Lifesciences Inc ::RESHAPE LIFESCIENCES INC - ‍RECEIVED ORDER FOR RESHAPE INTEGRATED DUAL BALLOON SYSTEM FROM AL ZAHRAWI MEDICAL​.  Full Article

Reshape Lifesciences qtrly loss per share $1.06‍​
Tuesday, 14 Nov 2017 04:04pm EST 

Nov 14 (Reuters) - Reshape Lifesciences Inc ::Reshape Lifesciences announces third quarter 2017 financial results.Q3 revenue $360,000.Reshape Lifesciences Inc - qtrly loss per share $1.06‍​.  Full Article

UPDATE 1-FDA reports 5 more deaths related to intragastric balloons

June 4 The U.S. Food and Drug Administration on Monday notified healthcare providers that it had received reports of five more deaths in patients using liquid-filled intragastric balloon systems to treat obesity, bringing the total death toll to 12 since 2016.